Search

everythinglearnresearchcommunity

for

Search:↓

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Stimulating OR10J1 can promote hair growth and may help treat hair loss.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

MR antagonists may improve skin health and wound healing, especially in aging.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Vitamin D receptor helps protect skin cells from UV damage and supports their growth.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

The vitamin D receptor is essential for skin stem cells to grow, move, and become different cell types needed for skin healing.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Sphingosine 1-phosphate and its receptor S1PR3 are key in controlling mechanical pain.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.